Pharmaceuticals Temperature Controlled Packaging Solutions Market Synopsis

Pharmaceuticals Temperature Controlled Packaging Solutions Market Size Was Valued at USD 5.56 Billion in 2023 and is Projected to Reach USD 10.23 Billion by 2032, Growing at a CAGR of 5.5% From 2024-2032

Pharmaceuticals Temperature Controlled Packaging Solutions Market deals with the exact packaging industry branch for development of the exact solutions and technologies for preservation needed during the storage and transportation of the pharmaceutical goods. This kind of technologies is necessary to ensure the stability and reliability of temperature and condition-sensitive pharmaceutical products including the medications, vaccines, and biologicals.

These markets encompass a variety of the packaging technologies, which are the heat-retained containers, temperature-controlled packaging materials, phase change materials, and cold chain logistics services. The prime motive of these technologies is to avoid temperature fluctuations which may hamper the quality attributes besides the effectiveness of pharmaceuticals especially with those that are extremely sensitive to temperature changes. The market is powered by the regulatory authority, the global distribution networks of pharmaceutical products, and the requirement of therapeutic proteins and personalized medicines, whose distribution should be done under strict temperature control channels.

• Currently, the market is growing at a rapid rate and is evolving at a fast pace because of the increased trends in demand for temperature-controlled packaging and transportation methods. Increasing production of food, beverages, and pharmaceutical products accounts for high-risk foods, whose reputation is either a lifeline or a death knell. In an aim to ensuring that tight delivery specifications are met, drug-manufacturing firms are now deploying complex package deliveries that are temperature controlled.
• The market situation is constantly in the state of technological supremacy, as the most advanced technologies for insulated transportation, phase change materials and monitoring systems electronically arise.
• The cargo pre-temperature range monitoring using these technologies is crucial since it keeps the products effective according to their required temperature during transportation. Additionally, the market continues to thrive as a result of growing pharmaceutical exports as part of increased need for cold chain logistics in both emerging and established economies.
• The primary companies in the industry concentrate in their R&D unit’s development of sustainable packaging materials which are reusable and friendly to the environment, an effort in line with influential global initiatives to sustain ecological goals. Such dedication helps solve environmental issues as well as makes more companies integrate ecological measures in their processes with the result of reduced packaging waste and optimized supply chain activities.
• In summary, the market for pharmaceuticals temperature-controlled packaging is growing at a rapid pace with continuous innovations necessitated by the conviction that the drugs which are temperature-sensitive should be reliably and securely transported when the increasingly strict regulations and transnational trade are taken into account.

Pharmaceuticals Temperature Controlled Packaging Solutions Market Trend Analysis

Emerging Trends in Pharmaceuticals Temperature-Controlled Packaging Solutions

• The increasing popularity of ATP systems is one of the most important trends that the pharmaceutical logistics industry can boast, particularly in relation to the shipping of biologics and specialty drugs. They are highly advanced systems capable of monitoring and controlling the temperature of the temperature sensitive products from the manufacturing areas till the customer which in turn helps in maintaining the right temperature conditions for the temperature sensitive drugs.
• PCM as a standard feature in active packaging is one of the many technological factors contributing to this trend. PCMs have the ability to increase and decrease significant amounts of thermal energy within transformations of the phase change process (melting/freezing and solidification). g. in the form of a change from one state to another (e.g. a solid turning into a liquid or vice versa). This property ensures that the temperature within PCMs remain relatively constant within certain thresholds and can act as a thermal insulator during transportation. PCMs can be used in packaging designs for biologics and specialty drugs to help pharmaceutical manufacturers in mitigating the effects of undesirable temperatures on the integrity of their products.
• The other prominent cold chain materials are VIPs and actives cooling systems essential for temperature-controlled packaging. VIPs have excellent thermal resistance and reduction in the flow of heat and can sustain comfortable interior temperatures for long periods among the VIPs. Cooling units produce cold air for maintaining controlled temperatures in compressors and are useful in harsh conditions where control is necessary. All of these technologies facilitate the pharmaceutical manufacturers and distributors to meet the highest standards of regulatory demands and effectively provide safe and effective medications to the patients globally. The increased use and development of such active temperature-controlled packaging processes clearly reflect the dedication of the industry to deliver exceptional pharmaceutical logistics solutions.

Advancements in IoT-Integrated Smart Packaging for Pharmaceuticals

• The introduction of smart packaging embracing IoT models for the pharmaceutical industry is a crucial step toward securing shipments and packaging. These value enhancing packaging technologies are fitted with a number of sensors and data recorders which constantly collect information regarding certain vital factors for instance, temperature, humidity, light and shock expression during transport. These sensors continuously monitor the physical and environmental parameters of each shipment and send the information to the pharmaceutical companies and logistics providers over the IoT networks in real-time.
• With the help of IoT capable smart packaging, companies that are involved in pharmaceutical supply chain achieve a higher degree of visibility and control over their cargo. Any variation of mentioned conditions such as temperature can trigger the sending of notifications to pre-defined users or systems to allow for rapid corrective actions that can potentially avoid adverse effects on sensitive medications. The level of monitoring and control in this case not only improve the overall quality and safety of pharmaceutical distribution but also help in the process of complying with the regulatory requirement as it provides a clear and accountable documentation on the environmental condition throughout the distribution of each drug product.
• In addition, the combination of IoT technology with smart packaging solutions supports the prescriptive business capabilities of the supply chain. Reviewing past trends and events captured by the IoT sensors will help the pharmaceutical companies to pinpoint the deficient links in the chain, develop more effective distribution routes for drugs and understand how the packaging of the drugs can be strengthened. At last, the future of smart pharmaceutical logistics lies in the creation of the Internet of Things-connected smart packaging solutions that ensure the quality and safety of the pharmaceutical products in a proactive way, as much as possible based on the data.

Pharmaceuticals Temperature Controlled Packaging Solutions Market Analysis:

Pharmaceuticals Temperature Controlled Packaging Solutions Market is segmented based on Product, Temperature Range, Application and End-User.

By Temperature Range, Cold Chain segment is expected to dominate the market during the forecast period

• Temperature-controlled packaging solutions such as Cold Chain solutions are the most heavily used in the overall temperature-controlled packaging market owing to the importance and necessity of this form of packaging for the transport and storage of highly sensitive vaccines and pharmaceutical products.
• Vaccines as an example have to be kept in certain temperatures for them to be effective and any alterations from the recommended temperature can cause ineffectiveness of these vaccines. Cold Chain packaging is a method for refrigerating products that utilizes specific materials and technologies like refrigerated containers, ice packs, and thermometers to maintain constant temperatures during transportation and storage.
• The growing global demand for vaccines and biologics further strengthens this segment’s power in the cold chain logistics market as it requires efficient and effective universal reach to remote and hard-to-reach populations without compromising on quality.

• On the other hand, Ambient/Controlled Room Temperature solutions feature greater application versatility targeting the pharmaceutical and healthcare industries. The third part of this segment is devoted to vehicles that are required to maintain the required temperature for medicines and medical equipment, which are less susceptible to temperature fluctuations than vaccines or biological drugs.
• Atmosphere packaging is the type of packaging where packaging materials are developed to prevent extreme heat or cold from damaging products but do not have to be refrigerated or handled in any special way. They have the advantage of being relatively more flexible and economically viable for the transport of pharmaceutical products that can be maintained at a higher temperature.
• And with the growth of the pharma companies and the diversification of their portfolios, from orphan drugs to oral solids as well as certain biologic molecules less sensitive to temperature variations, Ambient/Controlled Room Temperature packaging represents a critical enabler for the supply of these goods across different regions.

By Product, Reusable Solutions segment held the largest share in 2023

• In the domain of medical supply industry as well, a large volume of business is accounted for by the segment of reusable solutions, particularly in the context of temperature-sensitive pharmaceuticals. Modular approaches are extremely popular because they can be easily maintained and come at relatively low expenses which are also acceptable in terms of the common tendency to sustainability in the healthcare industries. Pharmaceutical and biotechnology organizations highly value reusable packaging for transporting temperature-sensitive products because it effectively prevents the finished products for becoming ineffective and harmful to human health, and it also allows for the minimization of packaging waste.
• The attraction of reusable solutions is that the solutions will be applied several times for the same purpose and therefore the client will be able to get the same quality and avoid the waste connected with single-use packaging. This sustainability aspect is particularly significant in the pharmaceutical sector because inefficient temperature control during transportation and storage directly contravenes medical product quality and regulatory standards.
• Reusable solutions do not only manage to fulfill these requirements efficiently but can also be an important factor that helps in minimizing operational costs and increasing supply chain performance which is precisely what pharmaceutical companies want for their logistic unit and their environment. Going forward, with increasing concerns and efforts towards sustainability, the demand, acceptance, and innovation of reusable solutions within the MSSL sector, particularly the cold chain for temperature-sensitive pharmaceuticals, will continue to expand.

Pharmaceuticals Temperature Controlled Packaging Solutions Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

• China has been identified as a developing market for pharmaceuticals temperature-controlled packaging solutions sector due to factors such as the growing pharmaceutical industry companies and investments in healthcare infrastructure. With a population that feels greater than 1. 4 billion and a growing middle class thus creating a significant market outlet for quality Pharmaceutical products; an advanced packaging system will therefore be required to preserve the potency of the pharmaceutical products during the supply process. The policies toward healthcare and medications in the Chinese market by ensuring the quality and efficacy of medications are still in practice further boost the demand for temperature-sensitive packaging, which maintains the integrity of the medications throughout the supply chain. While China further encourages and develops the pharmaceutical manufacturing industry and pharmaceutical exports and faces intensified requirements on standardized cold chain logistics solutions, products and technologies about temperature-sensitive packaging will show more development potentials and market opportunities.
• Even though India is still a developing market in terms of temperature-controlled packaging solutions for pharmaceuticals, it offers some of the greatest possibilities for growth due to the country’s increasing pharmaceutical exports and the ongoing progress of the cold chain transport infrastructure. India as a leader in production of generic drugs across continents and the fastest upcoming market for biopharmaceuticals Inc is utterly dependent on effective temperature controlled transportation for sustenance and adherence to international quality standards. The following interventions by the government to improve the cold chain system, especially in hard-to-reach areas, have played a critical role in spurring the growth of the pharmaceutical industry and driving the demand for pharma-packaging solutions. India is a developing country with a potential and growing pharmaceutical industry with a focus on quality of the products across the produce chain therefore the temperature sensitive packaging industry has extensive growth with investments and innovation to cater for the growing pharmaceutical industry.

Active Key Players in the Pharmaceuticals Temperature Controlled Packaging Solutions Market

• Pelican Biothermal
• Cryopak
• Sonoco Products Company
• Envirotainer
• DS Smith Pharma
• Cold Chain Technologies
• World Courier
• Intelsius
• CSafe
• Softbox Systems
• Skycell
• Va-Q-tec AG
• Sofrigam
• Other Key Players

Key Industry Developments in the Pharmaceuticals Temperature Controlled Packaging Solutions Market:

• In September 2023, the Celsure XL Pallet Shipper series and the Celsure VIP Multi-Use Parcel Shipper series, two new temperature-controlled packaging options were launched for the pharmaceutical business, according to Pluss Advanced Technologies (PLUSS), a company that develops phase-change material (PCM) technology.
• In February 2023, Minneapolis Peli BioThermal, a partner in the life science industry from research to distribution, expanded its line of reusable CrÄ“doTM shippers, which offer protection for deep frozen payloads. The wide range of CrÄ“do CubeTM Dry Ice products will help to alleviate the present dry ice shortages that are seriously affecting the pharmaceutical logistics sector. The need to securely deliver temperature-sensitive biologics as well as time-sensitive cell and gene therapies to patients is increasing, and the new devices will help satisfy this need.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BY PRODUCT (2017-2032)
   1. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. REUSABLE SOLUTIONS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. SINGLE USE SOLUTIONS
7. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BY TEMPERATURE RANGE (2017-2032)
   1. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. COLD CHAIN
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. AMBIENT/CONTROLLED ROOM TEMPERATURE
8. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BY APPLICATION (2017-2032)
   1. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. TEMPERATURE-SENSITIVE PHARMACEUTICALS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. VACCINES
   5. OTHERS
9. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BY END-USER (2017-2032)
   1. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. END-USERA
   4. PHARMACEUTICAL COMPANIES
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   5. BIOTECHNOLOGY COMPANIES
   6. HOSPITALS AND CLINICS
   7. OTHERS
10. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
       1. Competitive Positioning
       2. Pharmaceuticals Temperature Controlled Packaging Solutions Market Share By Manufacturer (2023)
       3. Industry BCG Matrix
       4. Heat Map Analysis
       5. Mergers & Acquisitions
    2. PELICAN BIOTHERMAL
       1. Company Overview
       2. Key Executives
       3. Company Snapshot
       4. Role of the Company in the Market
       5. Sustainability and Social Responsibility
       6. Operating Business Segments
       7. Product Portfolio
       8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
       9. Key Strategic Moves And Recent Developments
       10. SWOT Analysis
    3. CRYOPAK
    4. SONOCO PRODUCTS COMPANY
    5. ENVIROTAINER
    6. DS SMITH PHARMA
    7. COLD CHAIN TECHNOLOGIES
    8. WORLD COURIER
    9. INTELSIUS
    10. CSAFE
    11. SOFTBOX SYSTEMS
    12. SKYCELL
    13. VA-Q-TEC AG
    14. SOFRIGAM
11. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Product
       4. Historic And Forecasted Market Size By Temperature Range
       5. Historic And Forecasted Market Size By Application
       6. Historic And Forecasted Market Size By End-User
       7. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
12. INVESTMENT ANALYSIS
13. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET COMPETITIVE RIVALRY
TABLE 005. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET THREAT OF NEW ENTRANTS
TABLE 006. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET THREAT OF SUBSTITUTES
TABLE 007. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BY TYPE
TABLE 008. REUSABLE SOLUTIONS MARKET OVERVIEW (2016-2028)
TABLE 009. SINGLE USE SOLUTIONS MARKET OVERVIEW (2016-2028)
TABLE 010. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET BY APPLICATION
TABLE 011. TEMPERATURE-SENSITIVE PHARMACEUTICALS MARKET OVERVIEW (2016-2028)
TABLE 012. VACCINES MARKET OVERVIEW (2016-2028)
TABLE 013. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY APPLICATION (2016-2028)
TABLE 016. N PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY APPLICATION (2016-2028)
TABLE 019. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY APPLICATION (2016-2028)
TABLE 022. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY APPLICATION (2016-2028)
TABLE 025. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY APPLICATION (2016-2028)
TABLE 028. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, BY COUNTRY (2016-2028)
TABLE 029. SONOCO PRODUCTS COMPANY: SNAPSHOT
TABLE 030. SONOCO PRODUCTS COMPANY: BUSINESS PERFORMANCE
TABLE 031. SONOCO PRODUCTS COMPANY: PRODUCT PORTFOLIO
TABLE 032. SONOCO PRODUCTS COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. ENVIROTAINER: SNAPSHOT
TABLE 033. ENVIROTAINER: BUSINESS PERFORMANCE
TABLE 034. ENVIROTAINER: PRODUCT PORTFOLIO
TABLE 035. ENVIROTAINER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. PELICAN BIOTHERMAL: SNAPSHOT
TABLE 036. PELICAN BIOTHERMAL: BUSINESS PERFORMANCE
TABLE 037. PELICAN BIOTHERMAL: PRODUCT PORTFOLIO
TABLE 038. PELICAN BIOTHERMAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. CRYOPAK: SNAPSHOT
TABLE 039. CRYOPAK: BUSINESS PERFORMANCE
TABLE 040. CRYOPAK: PRODUCT PORTFOLIO
TABLE 041. CRYOPAK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. DS SMITH PHARMA: SNAPSHOT
TABLE 042. DS SMITH PHARMA: BUSINESS PERFORMANCE
TABLE 043. DS SMITH PHARMA: PRODUCT PORTFOLIO
TABLE 044. DS SMITH PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. COLD CHAIN TECHNOLOGIES: SNAPSHOT
TABLE 045. COLD CHAIN TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 046. COLD CHAIN TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 047. COLD CHAIN TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. INTELSIUS: SNAPSHOT
TABLE 048. INTELSIUS: BUSINESS PERFORMANCE
TABLE 049. INTELSIUS: PRODUCT PORTFOLIO
TABLE 050. INTELSIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. CSAFE: SNAPSHOT
TABLE 051. CSAFE: BUSINESS PERFORMANCE
TABLE 052. CSAFE: PRODUCT PORTFOLIO
TABLE 053. CSAFE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. SOFTBOX SYSTEMS: SNAPSHOT
TABLE 054. SOFTBOX SYSTEMS: BUSINESS PERFORMANCE
TABLE 055. SOFTBOX SYSTEMS: PRODUCT PORTFOLIO
TABLE 056. SOFTBOX SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. WORLD COURIER: SNAPSHOT
TABLE 057. WORLD COURIER: BUSINESS PERFORMANCE
TABLE 058. WORLD COURIER: PRODUCT PORTFOLIO
TABLE 059. WORLD COURIER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. SKYCELL: SNAPSHOT
TABLE 060. SKYCELL: BUSINESS PERFORMANCE
TABLE 061. SKYCELL: PRODUCT PORTFOLIO
TABLE 062. SKYCELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. VA-Q-TEC AG: SNAPSHOT
TABLE 063. VA-Q-TEC AG: BUSINESS PERFORMANCE
TABLE 064. VA-Q-TEC AG: PRODUCT PORTFOLIO
TABLE 065. VA-Q-TEC AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. SOFRIGAM: SNAPSHOT
TABLE 066. SOFRIGAM: BUSINESS PERFORMANCE
TABLE 067. SOFRIGAM: PRODUCT PORTFOLIO
TABLE 068. SOFRIGAM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. AMERICAN AEROGEL CORPORATION: SNAPSHOT
TABLE 069. AMERICAN AEROGEL CORPORATION: BUSINESS PERFORMANCE
TABLE 070. AMERICAN AEROGEL CORPORATION: PRODUCT PORTFOLIO
TABLE 071. AMERICAN AEROGEL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. ECOCOOL GMBH: SNAPSHOT
TABLE 072. ECOCOOL GMBH: BUSINESS PERFORMANCE
TABLE 073. ECOCOOL GMBH: PRODUCT PORTFOLIO
TABLE 074. ECOCOOL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. AERIS DYNAMICS: SNAPSHOT
TABLE 075. AERIS DYNAMICS: BUSINESS PERFORMANCE
TABLE 076. AERIS DYNAMICS: PRODUCT PORTFOLIO
TABLE 077. AERIS DYNAMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. DOKASCH: SNAPSHOT
TABLE 078. DOKASCH: BUSINESS PERFORMANCE
TABLE 079. DOKASCH: PRODUCT PORTFOLIO
TABLE 080. DOKASCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. HAZGO: SNAPSHOT
TABLE 081. HAZGO: BUSINESS PERFORMANCE
TABLE 082. HAZGO: PRODUCT PORTFOLIO
TABLE 083. HAZGO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. BEIJING ROLOO TECHNOLOGY CO.: SNAPSHOT
TABLE 084. BEIJING ROLOO TECHNOLOGY CO.: BUSINESS PERFORMANCE
TABLE 085. BEIJING ROLOO TECHNOLOGY CO.: PRODUCT PORTFOLIO
TABLE 086. BEIJING ROLOO TECHNOLOGY CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. LTD: SNAPSHOT
TABLE 087. LTD: BUSINESS PERFORMANCE
TABLE 088. LTD: PRODUCT PORTFOLIO
TABLE 089. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. INSULATED PRODUCTS CORPORATION: SNAPSHOT
TABLE 090. INSULATED PRODUCTS CORPORATION: BUSINESS PERFORMANCE
TABLE 091. INSULATED PRODUCTS CORPORATION: PRODUCT PORTFOLIO
TABLE 092. INSULATED PRODUCTS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 092. INMARK PACKAGING: SNAPSHOT
TABLE 093. INMARK PACKAGING: BUSINESS PERFORMANCE
TABLE 094. INMARK PACKAGING: PRODUCT PORTFOLIO
TABLE 095. INMARK PACKAGING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 095. COLD CHAIN TOOLS: SNAPSHOT
TABLE 096. COLD CHAIN TOOLS: BUSINESS PERFORMANCE
TABLE 097. COLD CHAIN TOOLS: PRODUCT PORTFOLIO
TABLE 098. COLD CHAIN TOOLS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 098. EXELTAINER SL: SNAPSHOT
TABLE 099. EXELTAINER SL: BUSINESS PERFORMANCE
TABLE 100. EXELTAINER SL: PRODUCT PORTFOLIO
TABLE 101. EXELTAINER SL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. INNO COOL PVT LTD: SNAPSHOT
TABLE 102. INNO COOL PVT LTD: BUSINESS PERFORMANCE
TABLE 103. INNO COOL PVT LTD: PRODUCT PORTFOLIO
TABLE 104. INNO COOL PVT LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. CRYO STORE: SNAPSHOT
TABLE 105. CRYO STORE: BUSINESS PERFORMANCE
TABLE 106. CRYO STORE: PRODUCT PORTFOLIO
TABLE 107. CRYO STORE: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY TYPE
FIGURE 012. REUSABLE SOLUTIONS MARKET OVERVIEW (2016-2028)
FIGURE 013. SINGLE USE SOLUTIONS MARKET OVERVIEW (2016-2028)
FIGURE 014. PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY APPLICATION
FIGURE 015. TEMPERATURE-SENSITIVE PHARMACEUTICALS MARKET OVERVIEW (2016-2028)
FIGURE 016. VACCINES MARKET OVERVIEW (2016-2028)
FIGURE 017. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET OVERVIEW BY COUNTRY (2016-2028)